EP3116897
Pólýmyxín-afleiður og notkun þeirra í samsettri meðferð ásamt mismunandi sýklalyfjum
:
EP einkaleyfi í gildi á Íslandi:
11.3.2015:
2.3.2022:
15715172.1
:
12.4.2022:
15.5.2022
:
10.3.2035:
10.3.2026:
31.3.2026
:
POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICS
11.3.2015
2.3.2022
12.4.2022
15.5.2022
10.3.2026
:
Spero Therapeutics, Inc.:
675 Massachusetts Avenue 14th Floor, Cambridge, Massachusetts 02139, US
:
BROWN, Pamela:
Reading Berkshire RG1 9LS, GB
:
DAWSON, Michael:
Reading Berkshire RG1 9LS, GB
:
SIMONOVIC, Mona:
Reading Berkshire RG1 9LS, GB
:
BOAKES, Steven:
Reading Berkshire RG1 9LS, GB
:
DUPERCHY, Esther:
Reading Berkshire RG1 9LS, GB
:
STANWAY, Steven James:
Ongar Essex CM5 0GS, GB
:
WILSON, Antoinette:
Ongar Essex CM5 0GS, GB
:
MOSS, Stephen Frederick:
Ongar Essex CM5 0GS, GB
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201404301:
11.3.2014:
GB
:
201421019:
26.11.2014:
GB
:
EP2015055046:
11.3.2015
:
C07K 7/62, A61K 38/12
: 8
: 11.4.2022
: 10.3.2023
: Árnason Faktor ehf.
: 9
: 12.2.2023
: 10.3.2024
: Árnason Faktor ehf.
: 10
: 12.2.2024
: 10.3.2025
: Árnason Faktor ehf.
: 11
: 29.1.2025
: 10.3.2026
: Árnason Faktor ehf.